Melphalan impurity B Di HCl salt
| Product Name | Melphalan impurity B Di HCl salt |
|---|---|
| Alternate Names | Melphalan Impurities, Impurities of Melphalan |
| CAT No. | CS-O-13766 |
| CAS No. | 1270153-04-2 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 323.22 g/mol |
| Mol. For. | C₁₃H₂₀Cl₂N₂O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Melphalan |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | N[C@H](C(O)=O)CC1=CC=C(C=C1)N2CCOCC2.[H]Cl.[H]Cl |
| Canonical Smiles | C1COCCN1C2=CC=C(C=C2)CC(C(=O)O)N |
| InchIKey | BKFTZFXJLYAYLN-LBPRGKRZSA-N |
| Inchl | InChI=1S/C13H18N2O3/c14-12(13(16)17)9-10-1-3-11(4-2-10)15-5-7-18-8-6-15/h1-4,12H,5-9,14H2,(H,16,17)/t12-/m0/s1 |
| IUPAC | (2S)-2-amino-3-(4-morpholin-4-ylphenyl)propanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Melphalan EP Impurity B is a chemical compound that is commonly used in the pharmaceutical industry as an impurity in Melphalan, a chemotherapy drug used to treat various types of cancer such as multiple myeloma and ovarian cancer. Melphalan EP Impurity B is a degradation product of Melphalan and is formed during the manufacturing process or storage of the drug.
Chemically, Melphalan EP Impurity B is known as 4-([bis(2-chloroethyl)amino]methyl)benzene-1,2-diol and has a molecular weight of 338.22 g/mol. It is a white to off-white crystalline powder that is sparingly soluble in water but soluble in organic solvents like methanol and acetonitrile.
Melphalan EP Impurity B is usually present in small amounts in Melphalan formulations, and its concentration is closely monitored and controlled during the drug’s manufacturing and storage process. The presence of Melphalan EP Impurity B in Melphalan formulations can potentially affect the drug’s efficacy, safety, and stability.
To ensure the safety and efficacy of Melphalan, pharmaceutical companies must adhere to strict regulations set by regulatory bodies like the United States Pharmacopeia (USP) and the European Pharmacopoeia (EP) regarding the allowable concentration limits of Melphalan EP Impurity B in Melphalan formulations. Overall, Melphalan EP Impurity B plays an important role in the quality control and safety of Melphalan formulations used in cancer treatment.
Get an Instant Quote
Related Compounds
Melphalan EP Impurity D DiHCl | Melphalan Ethyl Ester | Melphalan EP Impurity B Hydrochloride | Melphalan EP Impurity A | Melphalan EP Impurity C | Melphalan Ethyl Ester hydrochloride | Melphalan EP Impurity F | Melphalan EP Impurity I | Melphalan EP Impurity H | Melphalan Isopropyl Ester Hydrochloride | Melphalan EP Impurity E | Melphalan EP Impurity C- HCl | Melphalan Methyl Ester Hydrochloride | Melphalan Isopropyl Ester | Melphalan EP impurity C Di hydrochloride | Melphalan EP Impurity A Hydrochloride | Melphalan EP Impurity G | Melphalan EP Impurity D | Melphalan EP Impurity J | Melphalan HCI Enantiomer |